285 related articles for article (PubMed ID: 18498876)
1. Cyclooxygenase-2 induces genomic instability, BCL2 expression, doxorubicin resistance, and altered cancer-initiating cell phenotype in MCF7 breast cancer cells.
Singh B; Cook KR; Vincent L; Hall CS; Berry JA; Multani AS; Lucci A
J Surg Res; 2008 Jun; 147(2):240-6. PubMed ID: 18498876
[TBL] [Abstract][Full Text] [Related]
2. Cyclooxygenase-2 expression induces genomic instability in MCF10A breast epithelial cells.
Singh B; Vincent L; Berry JA; Multani AS; Lucci A
J Surg Res; 2007 Jun; 140(2):220-6. PubMed ID: 17418864
[TBL] [Abstract][Full Text] [Related]
3. Altered expression of proliferation-inducing and proliferation-inhibiting genes might contribute to acquired doxorubicin resistance in breast cancer cells.
Saleh EM; El-Awady RA; Abdel Alim MA; Abdel Wahab AH
Cell Biochem Biophys; 2009; 55(2):95-105. PubMed ID: 19593673
[TBL] [Abstract][Full Text] [Related]
4. Differential responses to doxorubicin-induced phosphorylation and activation of Akt in human breast cancer cells.
Li X; Lu Y; Liang K; Liu B; Fan Z
Breast Cancer Res; 2005; 7(5):R589-97. PubMed ID: 16168102
[TBL] [Abstract][Full Text] [Related]
5. Bcl2-negative MCF7 cells overexpress p53: implications for the cell cycle and sensitivity to cytotoxic drugs.
Poliseno L; Mariani L; Collecchi P; Piras A; Zaccaro L; Rainaldi G
Cancer Chemother Pharmacol; 2002 Aug; 50(2):127-30. PubMed ID: 12172977
[TBL] [Abstract][Full Text] [Related]
6. Identification of 14-3-3sigma as a contributor to drug resistance in human breast cancer cells using functional proteomic analysis.
Liu Y; Liu H; Han B; Zhang JT
Cancer Res; 2006 Mar; 66(6):3248-55. PubMed ID: 16540677
[TBL] [Abstract][Full Text] [Related]
7. Effects and mechanism of downregulation of COX‑2 expression by RNA interference on proliferation and apoptosis of human breast cancer MCF‑7 cells.
Han H; Yang S; Lin SG; Xu CS; Han ZH
Mol Med Rep; 2014 Dec; 10(6):3092-8. PubMed ID: 25323004
[TBL] [Abstract][Full Text] [Related]
8. Bcl-2 slows in vitro breast cancer growth despite its antiapoptotic effect.
Knowlton K; Mancini M; Creason S; Morales C; Hockenbery D; Anderson BO
J Surg Res; 1998 Apr; 76(1):22-6. PubMed ID: 9695733
[TBL] [Abstract][Full Text] [Related]
9. Linalool, a plant-derived monoterpene alcohol, reverses doxorubicin resistance in human breast adenocarcinoma cells.
Ravizza R; Gariboldi MB; Molteni R; Monti E
Oncol Rep; 2008 Sep; 20(3):625-30. PubMed ID: 18695915
[TBL] [Abstract][Full Text] [Related]
10. Cox-2 expression on tissue microarray of breast cancer.
Park K; Han S; Shin E; Kim HJ; Kim JY
Eur J Surg Oncol; 2006 Dec; 32(10):1093-6. PubMed ID: 16797158
[TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of tissue transglutaminase in drug resistant and metastatic breast cancer.
Mehta K; Fok J; Miller FR; Koul D; Sahin AA
Clin Cancer Res; 2004 Dec; 10(23):8068-76. PubMed ID: 15585642
[TBL] [Abstract][Full Text] [Related]
12. COX-2 overexpression increases motility and invasion of breast cancer cells.
Singh B; Berry JA; Shoher A; Ramakrishnan V; Lucci A
Int J Oncol; 2005 May; 26(5):1393-9. PubMed ID: 15809733
[TBL] [Abstract][Full Text] [Related]
13. REIC/Dkk-3 overexpression downregulates P-glycoprotein in multidrug-resistant MCF7/ADR cells and induces apoptosis in breast cancer.
Kawasaki K; Watanabe M; Sakaguchi M; Ogasawara Y; Ochiai K; Nasu Y; Doihara H; Kashiwakura Y; Huh NH; Kumon H; Date H
Cancer Gene Ther; 2009 Jan; 16(1):65-72. PubMed ID: 18654608
[TBL] [Abstract][Full Text] [Related]
14. Prediction of doxorubicin sensitivity in breast tumors based on gene expression profiles of drug-resistant cell lines correlates with patient survival.
Györffy B; Serra V; Jürchott K; Abdul-Ghani R; Garber M; Stein U; Petersen I; Lage H; Dietel M; Schäfer R
Oncogene; 2005 Nov; 24(51):7542-51. PubMed ID: 16044152
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of ΔNp63α induces a stem cell phenotype in MCF7 breast carcinoma cell line through the Notch pathway.
Du Z; Li J; Wang L; Bian C; Wang Q; Liao L; Dou X; Bian X; Zhao RC
Cancer Sci; 2010 Nov; 101(11):2417-24. PubMed ID: 20950370
[TBL] [Abstract][Full Text] [Related]
16. Differential modulation by estradiol of P-glycoprotein drug resistance protein expression in cultured MCF7 and T47D breast cancer cells.
Zampieri L; Bianchi P; Ruff P; Arbuthnot P
Anticancer Res; 2002; 22(4):2253-9. PubMed ID: 12174911
[TBL] [Abstract][Full Text] [Related]
17. Resistance to paclitaxel therapy is related with Bcl-2 expression through an estrogen receptor mediated pathway in breast cancer.
Tabuchi Y; Matsuoka J; Gunduz M; Imada T; Ono R; Ito M; Motoki T; Yamatsuji T; Shirakawa Y; Takaoka M; Haisa M; Tanaka N; Kurebayashi J; Jordan VC; Naomoto Y
Int J Oncol; 2009 Feb; 34(2):313-9. PubMed ID: 19148464
[TBL] [Abstract][Full Text] [Related]
18. COX-2 induces IL-11 production in human breast cancer cells.
Singh B; Berry JA; Shoher A; Lucci A
J Surg Res; 2006 Apr; 131(2):267-75. PubMed ID: 16457848
[TBL] [Abstract][Full Text] [Related]
19. Progesterone sensitizes breast cancer MCF7 cells to imatinib inhibitory effects.
Rocha A; Azevedo I; Soares R
J Cell Biochem; 2008 Feb; 103(2):607-14. PubMed ID: 17614352
[TBL] [Abstract][Full Text] [Related]
20. Long duration exposure to cadmium leads to increased cell survival, decreased DNA repair capacity, and genomic instability in mouse testicular Leydig cells.
Singh KP; Kumari R; Pevey C; Jackson D; DuMond JW
Cancer Lett; 2009 Jun; 279(1):84-92. PubMed ID: 19232459
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
